Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus

Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients

(2012) M-L. Luong et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis

(2012) Nicola Bizzaro et al.   AUTOIMMUNITY REVIEWS

Simultaneous Positivity for Anti-DNA, Anti-Nucleosome and Anti-Histone Antibodies is a Marker for More Severe Lupus Nephritis

(2012) Mansu Sui et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers

(2011) E Akhter et al.   LUPUS

Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus

(2011) Robert Biesen et al.   ARTHRITIS RESEARCH & THERAPY

Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study

(2009) Jessica J Manson et al.   ARTHRITIS RESEARCH & THERAPY

Antinucleosome Antibodies as a Marker of Active Proliferative Lupus Nephritis

(2008) Cornelia Bigler et al.   AMERICAN JOURNAL OF KIDNEY DISEASES